Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
Е. Л. Насонов(Association of Rheumatologists of Russia), А. I. Zagrebneva(Pirogov Russian National Research Medical University), А. М. Лила(Russian Medical Academy of Continuous Professional Education), Б. С. Белов(Unknown), O. A. Nikitinskaya, Д. И. Абдулганиева(Kazan State Medical University), А. Е. Каратеев, А. А. Баранов(Yaroslavl State Medical Academy), Sergey Moiseev(Sechenov University), Т. В. Дубинина(Association of Rheumatologists of Russia), Mazurov Vi(Ministry of Health of the Russian Federation)
Cited by 54
Related Papers
RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINES
|Rheumatology Science and Practice|2018|151
Federal clinical guidelines for diagnosis, treatment and prevention of osteoporosis
|Osteoporosis and Bone Diseases|2021|110
Russian federal clinical guidelines on the diagnostics, treatment, and prevention of osteoporosis
|Problems of Endocrinology|2018|101
Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice»
|Modern Rheumatology Journal|2015|86
GENERAL PRINCIPLES OF TREATMENT FOR MUSCULOSKELETAL PAIN: INTERDISCIPLINARY CONSENSUS
|Rheumatology Science and Practice (Nauchno-prakticheskaya revmatologiya) (IMA Press)|2016|62